Josh Gottheimer sold BioCryst Pharmaceuticals Inc (NASDAQ: BCRX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 3 trades in BioCryst Pharmaceuticals Inc (BCRX) since 2022, 2 purchases and 1 sale, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) on September 15, 2023. Since that trade, BCRX is up +39.12% against the S&P 500 up +69.74%, an outperformance of -30.62%.
Across these filings, Josh Gottheimer has been a net buyer of BCRX (a buy-to-sell ratio of 2.00). The most recent disclosed BCRX transaction shown was dated October 16, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's BCRX trades vs the price
BCRX is up +39.12% since Josh Gottheimer sold on September 15, 2023, versus +69.74% for the S&P 500.
Performance since this trade
All Josh Gottheimer BCRX trades
Josh Gottheimer & BCRX trading FAQ
Is it legal for Josh Gottheimer to trade BioCryst Pharmaceuticals Inc (BCRX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including BioCryst Pharmaceuticals Inc (BCRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell BCRX?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of BioCryst Pharmaceuticals Inc (BCRX) on September 15, 2023, according to public STOCK Act filings.
How has BCRX performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold BCRX on September 15, 2023, the stock is up +39.12%, versus +69.74% for the S&P 500 over the same period, an outperformance of -30.62%.
How many times has Josh Gottheimer traded BCRX?
Josh Gottheimer has disclosed 3 BCRX trades since 2022 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BCRX trades?
Quantellect tracks every disclosed congressional trade in BioCryst Pharmaceuticals Inc (BCRX) on the BioCryst Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's BCRX tradesAll congressional filings for BioCryst Pharmaceuticals IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.